RXO files prospectus supplement for resale of 28.5M shares by selling stockholders

RXO, Inc.

Filed prospectus supplement for resale of 28,514,952 shares by certain selling stockholders.
Consists of 22,255,481 outstanding shares and 6,259,471 shares issuable on pre-funded warrant exercise.
The registration is for existing stockholders, not a primary offering by RXO.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.